Clinical Trials Logo

Clinical Trial Summary

Partial nephrectomy (kidney removal) is a standard therapy for clinical T1 renal (kidney) tumors. The goals of surgery are to accurately remove the tumor with no cancer cells at the edge of the remaining tissue, to limit blood loss, and preserve kidney function. The most common technique is to clamp the blood supply to the entire kidney during removal and to surgically repair the tumor bed with suture and agents to stop bleeding. This stops the blood supply to the entire kidney including the healthy tissue, which can cause damage to the remaining tissue due to a shortage of oxygen if left clamped too long.

This study uses a microwave pre-coagulation technique using the Certus 140™ to facilitate a bloodless area near the tumor for accurate tumor removal and repair, while avoiding clamping the blood supply, but its effect on the function of kidney adjacent to tumor is unknown. If adequate stoppage of bleeding is achieved using the Certus 140™ with minimal heat spreading to the remaining tissue, clamping and a shortage of oxygen can be avoided.

The hypothesis is that microwave pre-coagulation is a safe method for providing the stoppage of bleeding during partial kidney removal.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01931462
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Terminated
Phase N/A
Start date August 2014
Completion date December 2016

See also
  Status Clinical Trial Phase
Terminated NCT02669914 - MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting NCT02121730 - Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Not yet recruiting NCT05241561 - Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients Phase 2
Completed NCT00199888 - Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. Phase 1
Completed NCT05363072 - A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Withdrawn NCT04127318 - Low-moderate Intensity Pedaling During Immunotherapy Administration N/A
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting NCT05732857 - Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy N/A
Recruiting NCT03133286 - Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Completed NCT02145559 - A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors Phase 1